Polynucleotide vaccine formulations

Details Polynucleotide vaccine formulations Polynucleotide vaccine formulations

A - Human Necessities

01

N

A01N 63/00 (2006.01) A01N 43/04 (2006.01) A61K 31/70 (2006.01) A61K 39/102 (2006.01) A61K 39/145 (2006.01) A61K 39/21 (2006.01) A61K 39/245 (2006.01) A61K 39/29 (2006.01) A61K 39/39 (2006.01) A61K 48/00 (2006.01) A01N 65/00 (2006.01)

Patent

CA 2280839

The present invention relates to a novel vaccine formulation comprising nucleic acid molecules and a mineral-based adjuvant provided in a biologically effective concentration so as to improve induction of an immune response subsequent to vaccination which correlates to expression of one or more specific antigens encoded by the nucleic acid molecule.

L'invention porte sur une nouvelle formule de vaccin comportant des molécules d'acide nucléique et un adjuvant à base minérale à une concentration à efficacité biologique améliorant l'induction de la réaction immunitaire suite à une vaccination, en corrélation avec l'expression d'un ou plusieurs antigènes spécifiques codés par la molécule d'acide nucléique.

Affiliated with

Also associated with

Rating

Polynucleotide vaccine formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polynucleotide vaccine formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polynucleotide vaccine formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1625148